Clinical Trial Update: Efficacy of Topical Gentamycin for Hereditary Hypotrichosis Simplex Caused by Nonsense Mutations in CDSN [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluates the efficacy of topical gentamicin for hereditary hypotrichosis simplex caused by nonsense mutations in the CDSN gene.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hypotrichosis Simplex

Drugs mentioned

• Gentamicin (gentamicin)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Hereditary Hypotrichosis Simplex | Phase 2 | Status: UNKNOWN